Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Nanayakkara J, Tyryshkin K, Yang X, Wong JJ, Vanderbeck K, Ginter PS, et al. Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining. NAR Cancer. 2020;2(3):zcaa009.

Roytman M, Pisapia DJ, Liechty B, Lin E, Skafida M, Magge RS, et al. Somatostatin receptor-2 negative meningioma: pathologic correlation and imaging implications. Clin Imaging. 2020;66:18-22.

Braunstein MJ, Petrova-Drus K, Rosenbaum CA, Jayabalan DS, Rossi AC, Salvatore S, et al. Plasma Cell Myeloma Presenting With Amyloid-Laden Crystal-Negative Histiocytosis. Am J Clin Pathol. 2020;154(6):767-775.

Lu Y, Lin M, Zong J, Zong L, Zhao Z, Wang S, et al. Highly bioavailable curcumin preparation with a co-grinding and solvent-free process. Food Sci Nutr. 2020;8(12):6415-6425.

J Mulvey J, Magro CM, Ma LX, Nuovo GJ, Baergen RN. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients. Ann Diagn Pathol. 2020;46:151530.

Butler LM, Perone Y, Dehairs J, Lupien LE, de Laat V, Talebi A, et al. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv Drug Deliv Rev. 2020;159:245-293.

Haas M, Seshan SV, Barisoni L, Amann K, Bajema IM, Becker JU, et al. Consensus definitions for glomerular lesions by light and electron microscopy: recommendations from a working group of the Renal Pathology Society. Kidney Int. 2020;98(5):1120-1134.

Yang HS, Hou Y, Vasovic LV, Steel PA, Chadburn A, Racine-Brzostek SE, et al. Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning. Clin Chem. 2020;66(11):1396-1404.

Shah MA, Mayer S, Emlen F, Sholle E, Christos P, Cushing M, et al. Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer. JAMA Netw Open. 2020;3(9):e2023121.

Beltran H, Romanel A, Conteduca V, Casiraghi N, Sigouros M, Franceschini GM, et al. Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer. J Clin Invest. 2020;130(4):1653-1668.